Planta Med 2011; 77(2): 188-195
DOI: 10.1055/s-0030-1250145
Biological Screening
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Quorum Sensing Inhibitors of Staphylococcus aureus from Italian Medicinal Plants

Cassandra L. Quave1 , Lisa R. W. Plano2 , Bradley C. Bennett1
  • 1Department of Biological Sciences, Florida International University, Miami, FL, USA
  • 2Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA
Further Information

Publication History

received January 24, 2010 revised June 23, 2010

accepted June 26, 2010

Publication Date:
19 July 2010 (online)

Abstract

Morbidity and mortality estimates due to methicillin-resistant Staphylococcus aureus (MRSA) infections continue to rise. Therapeutic options are limited by antibiotic resistance. Anti-pathogenic compounds, which inhibit quorum sensing (QS) pathways, may be a useful alternative to antibiotics. Staphylococcal QS is encoded by the agr locus and is responsible for the production of δ-hemolysin. Quantification of δ-hemolysin found in culture supernatants permits the analysis of agr activity at the translational rather than transcriptional level. We employed reversed phase high performance chromatographic (RP-HPLC) techniques to investigate the anti-QS activity of 168 extracts from 104 Italian plants through quantification of δ-hemolysin. Extracts from three medicinal plants (Ballota nigra, Castanea sativa, and Sambucus ebulus) exhibited a dose-dependent response in the production of δ-hemolysin, indicating anti-QS activity in a pathogenic MRSA isolate.

References

  • 1 Klevens R M, Edwards J R, Tenover F C, McDonald L C, Horan T, Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003.  Clin Infect Dis. 2006;  43 387-388
  • 2 Gould I M. Community-acquired MRSA: can we control it?.  Lancet. 2006;  368 824-826
  • 3 Yamamoto T, Nishiyama A, Takano T, Yabe S, Higuchi W, Razvina O, Shi D. Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance.  J Infect Chemother. ;  , [in press]
  • 4 Hildron A I, Low C E, Honig E G, Blumberg H M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia.  Lancet Infect Dis. 2009;  9 384-392
  • 5 Klevens R M, Morrison M, Nadle J, Petit S, Gershman K, Ray S, Harrison L H, Lynfield R, Dumyati G, Townes J M, Craig A S, Zell E R, Fosheim G, McDougal L K, Carey R B, Fridkin S K. Invasive methicillin-resistant Staphylococcus aureus infections in the United States.  JAMA. 2007;  298 1763-1771
  • 6 Gibbons S, Oluwatuyi M, Kaatz G W. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus.  J Antimicrob Chemother. 2003;  51 13-17
  • 7 Gibbons S, Oluwatuyi M, Veitch N C, Gray A I. Bacterial resistance modifying agents from Lycopus europaeus.  Phytochemistry. 2003;  62 83-87
  • 8 Gibbons S, Udo E E. The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant.  Phytother Res. 2000;  14 139-140
  • 9 Pereda-Miranda R, Kaatz G W, Gibbons S. Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistamce in Staphylococcus aureus.  J Nat Prod. 2006;  69 406-409
  • 10 Sakoulas G, Eliopoulos G M, Moellering R C, Wennersten C, Venkataraman L, Novick R P, Gold H S. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.  Antimicrob Agents Chemother. 2002;  46 1492-1502
  • 11 Otto M, Götz F. Analysis of quorum sensing activity in staphylococci by RP-HPLC of staphylococcal delta-toxin.  BioTechniques. 2000;  28 1088-1096
  • 12 Somerville G A, Cockayne A, Durr M, Peschel A, Otto M, Musser J M. Synthesis and deformylation of Staphylococcus aureus δ-toxin are linked to tricarboxylic acid cycle activity.  J Bacteriol. 2003;  185 6686-6694
  • 13 Otto M. Quorum-sensing control in Staphylococci – a target for antimicrobial drug therapy?.  FEMS Microbiol Lett. 2004;  241 135-141
  • 14 Dell'Acqua G, Giacometti A, Cirioni O, Ghiselli R, Saba V, Scalise G, Gov Y, Balaban N. Suppression of drug-resistant staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.  J Infect Dis. 2004;  190 318-320
  • 15 Balaban N, Goldkorn T, Nhan R T, Dang L B, Scott S, Ridgley R M, Rasooly A, Wright S C, Carlson J R. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus.  Science. 1998;  280 438-440
  • 16 Otto M, Submuth R, Vuong C, Jung G, Gotz F. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives.  FEBS Lett. 1999;  450 257-262
  • 17 Mayville P, Ji G, Beavis R, Yang H, Goger M, Novick R P, Muir T W. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence.  Proc Natl Acad Sci USA. 1999;  96 1218-1223
  • 18 Li M, Diep B A, Villaruz A E, Braughton K R, Jiang X, DeLeo F R, Chambers H F, Lu Y, Otto M. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus.  Proc Natl Acad Sci USA. 2009;  106 5883-5888
  • 19 NARSA .The Network on Antimicrobial Resistance in Staphylococcus aureushttp://www.narsa.net Accessed March 20, 2010
  • 20 McDougal L K, Steward C D, Killgore G E, Chaitram J, McAllister S K, Tenover F C. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database.  J Clin Microbiol. 2003;  41 5113-5120
  • 21 Pieroni A, Nebel S, Quave C L, Munz H, Heinrich M. Ethnopharmacology of liakra: traditional weedy vegetables of the Arbëreshë of the Vulture area in southern Italy.  J Ethnopharmacol. 2002;  81 165-185
  • 22 Pieroni A, Quave C L, Nebel S, Heinrich M. Ethnopharmacy of the ethnic Albanians (Arbëreshë) of northern Basilicata, Italy.  Fitoterapia. 2002;  73 217-241
  • 23 Pieroni A, Quave C L. Traditional pharmacopoeias and medicines among Albanians and Italians in southern Italy: a comparison.  J Ethnopharmacol. 2005;  101 258-270
  • 24 Quave C L, Pieroni A, Bennett B C. Dermatological remedies in the traditional pharmacopoeia of Vulture-Alto Bradano, inland southern Italy.  J Ethnobio Ethnomed. 2008;  4 5
  • 25 Isenberg H D. Clinical microbiology procedures handbook, 2nd edition. Washington D.C.; ASM Press 2004
  • 26 NCCLS .Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 5th edition. Wayne, PA; National Center for Clinical Laboratory Standards 2001
  • 27 Quave C L, Plano L W R, Pantuso T, Bennett B C. Effects of extracts from Italian medicinal plants on planktonic growth, biofilm formation and adherence of methicillin-resistant Staphylococcus aureus.  J Ethnopharmacol. 2008;  118 418-428
  • 28 Quave C L. An ethnopharmacological approach to multi-drug resistant Staphylococcus aureus: Evaluation of Italian plants used in the traditional healing of skin disease [dissertation]. Miami, FL; Florida International University 2008: 169
  • 29 Dunman P M, Murphy E, Haney S, Palacios D, Tucker-Kellogg G, Wu S, Brown E L, Zagursky R J, Shlaes D, Projan S J. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci.  J Bacteriol. 2001;  183 7341-7353
  • 30 Harraghy N, Kerdudou S, Herrmann M. Quorum-sensing systems in staphylococci as therapeutic targets.  Anal Bioanal Chem. 2007;  387 437-444
  • 31 Pieroni A, Quave C L, Santoro R F. Folk pharmaceutical knowledge in the territory of the Dolomiti Lucane, inland southern Italy.  J Ethnopharmacol. 2004;  95 373-384
  • 32 Kültür Ş. Medicinal plants used in Kirklareli Province (Turkey).  J Ethnopharmacol. 2007;  111 341-364
  • 33 Vrchovska V, Spilkova J, Valentao P, Sousa C, Andrade P B, Seabra R M. Antioxidative properties and phytochemical composition of Ballota nigra infusion.  Food Chem. 2007;  105 1396-1403
  • 34 Seidel V, Bailleul F, Libot F, Tillequin F. A phenylpropanoid glycoside from Ballota nigra.  Phytochemistry. 1997;  44 691-693
  • 35 Daels-Rakotoarison D A, Seidel V, Gressier B, Brunet C, Tillequin F, Bailleul F, Luyckx M, Dine T, Cazin M, Cazin J-C. Neurosedative and antioxidant activities of phenylpropanoids from Ballota nigra.  Arzneimittelforschung. 2000;  50 16-23
  • 36 Didry N, Seidel V, Dubreuil L, Tillequin F, Bailleul F. Isolation and antibacterial activity of phenylpropanoid derivatives from Ballota nigra.  J Ethnopharmacol. 1999;  67 197-202
  • 37 Bertrand M-C, Tillequin F, Bailleul F. Two major flavonoids from Ballota nigra.  Biochem Syst Ecol. 2000;  28 1031-1033
  • 38 Basile A, Sorbo S, Giordano S, Ricciardi L, Ferrara S, Montesano D, Cobianchi R C, Vuotto M L, Ferrara L. Antibacterial and allelopathic activity of extract from Castanea sativa leaves.  Fitoterapia. 2000;  71 S110-S116
  • 39 Süntar I P, Akkol E K, Yalçin F N, Koca U, Keleş H, Yesilada E. Wound healing potential of Sambucus ebulus L. leaves and isolation of an active component, quercetin 3-O-glucoside.  J Ethnopharmacol. 2010;  129 106-114

Dr. Cassandra L. Quave

Department of Microbiology and Immunology
College of Medicine
University of Arkansas for Medical Sciences

4301 W. Markham St.

Mail Slot 511

Little Rock, AR 72205-7199

USA

Phone: + 17 8 62 39 80 46

Fax: + 15 0 16 86 53 59

Email: cassy.quave@gmail.com

>